StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Investment analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALAGet Free Report) in a research note issued to investors on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

CALA stock opened at $0.02 on Friday. The business has a 50 day moving average price of $0.02 and a 200 day moving average price of $0.03. Calithera Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.50.

About Calithera Biosciences

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Read More

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.